1188TiP NICE-NEC, a phase II study of platinum-doublet chemotherapy in combination with nivolumab as first-line treatment in subjects with unresectable, locally advanced or metastatic grade 3 neuroendocrine neoplasms (NENs) of the gastroenteropancreatic tract or of unknown origin. GETNE-T1913

1188TiP NICE-NEC, a phase II study of platinum-doublet chemotherapy in combination with nivolumab as first-line treatment in subjects with unresectable, locally advanced or metastatic grade 3 neuroendocrine neoplasms (NENs) of the gastroenteropancreatic tract or of unknown origin. GETNE-T1913

Saved in:
Bibliographic Details
Published in:Annals of oncology Vol. 31; p. S783
Main Authors: Martínez, M.C. Riesco, Capdevila, J., Alonso, V., Teule, A., Grande, E., Jimenez-Fonseca, P., Benavent, M., Gordoa, T. Alonso, Custodio, A., Carbó, C. Hierro, López, C., García, I. Sevilla, García-Carbonero, R.
Format: Journal Article
Language:English
Published: Elsevier Ltd 01-09-2020
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0923-7534
1569-8041
DOI:10.1016/j.annonc.2020.08.2092